Streetbeat News

Analyst Ratings

UNM

JP Morgan analyst Jimmy Bhullar maintains an Overweight rating on Unum Group (NYSE:UNM) but lowers the price target from $65 to $63.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 4:08 pm

SRRK

JP Morgan analyst Tessa Romero maintains an Overweight rating on Scholar Rock Holding (NASDAQ:SRRK) but lowers the price target from $20 to $18.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 4:07 pm

WULF

Cantor Fitzgerald analyst Brett Knoblauch has reiterated an Overweight rating on TeraWulf (NASDAQ:WULF) and maintained a $10 price target.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 4:06 pm

NOV

JP Morgan analyst Arun Jayaram maintains an Overweight rating on NOV but lowers the price target from $23 to $22.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 4:06 pm

RPM

JP Morgan analyst Jeffrey Zekauskas maintains a Neutral rating on RPM International (NYSE:RPM) and raises the price target from $120 to $126.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 4:04 pm

RGA

JP Morgan analyst Jimmy Bhullar maintains a Neutral rating on Reinsurance Group of America (NYSE:RGA) and raises the price target from $220 to $222.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 4:03 pm

RPM

Deutsche Bank analyst David Huang maintains a Buy rating on RPM International (NYSE:RPM) and raises the price target from $132 to $140.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 4:02 pm

CALX

In the last three months, 9 analysts have provided ratings for Calix (NYSE:CALX), with 8 being bullish and 1 indifferent. The average 12-month price target has increased by 8.88% to $45.00. Analysts have maintained or raised their ratings, reflecting positive sentiment despite Calix's recent revenue decline.

Portfolio Pulse from Benzinga Insights

October 03, 2024 | 4:01 pm

BLBD

In the past three months, six analysts have shared their evaluations of Blue Bird (NASDAQ:BLBD), with a range of ratings from bullish to bearish. The average 12-month price target has increased by 9.1% to $62.0. Blue Bird has shown strong financial performance with a 13.28% revenue growth rate, a net margin of 8.61%, and a return on equity of 23.62%.

Portfolio Pulse from Benzinga Insights

October 03, 2024 | 4:01 pm

MODV

Analysts have provided mixed ratings for ModivCare (NASDAQ:MODV) over the past three months, with a recent average price target of $24.0, down 25.58% from previous estimates. The company's financials show challenges in revenue growth and debt management, despite a strong market position.

Portfolio Pulse from Benzinga Insights

October 03, 2024 | 4:00 pm